A simple method for measuring human cell-bound IgE levels in whole blood.

J Immunol Methods

Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Published: April 2009

IgE plays a critical role in hypersensitivity reactions such as asthma and allergy as well as poorly defined roles in immunity to parasitic helminth infections. The quantity of antigen-specific IgE is thought to affect the intensity of the allergic reaction as well as the perceived level of resistance to parasitic worms. Because most somatic IgE is bound by its receptors, Fc epsilon RI and Fc epsilon RII, and increased expression of IgE receptors also change with cellular activation status, the serum concentration of IgE may not necessarily reflect levels of systemic IgE. Accurate measures of IgE would help to define the bona fide role of this molecule in immunity. Furthermore, improved indicators of systemic antigen-specific IgE could better predict the risk for severe allergic responses. In this report, we demonstrate a simple method for measuring cell-bound IgE in whole blood using basic flow cytometry. This method demonstrates that, in general, cell-bound IgE correlates well with serum levels of IgE. However, discordance in serum and cell-bound IgE levels in some individuals illustrates the inadequacy of using serum levels of IgE as a systemic indicator and validates the need to assay both cell-bound and free IgE

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888851PMC
http://dx.doi.org/10.1016/j.jim.2009.01.012DOI Listing

Publication Analysis

Top Keywords

cell-bound ige
16
ige
15
simple method
8
method measuring
8
ige levels
8
antigen-specific ige
8
serum levels
8
levels ige
8
cell-bound
5
levels
5

Similar Publications

Nephrotic syndrome (NS) and atopic diseases are linked through shared immunological pathways, with allergic triggers often contributing to NS relapses, particularly in immunoglobulin E (IgE)-mediated pathways. Omalizumab, a humanized monoclonal antibody targeting free and cell-bound IgE, is commonly used in treating atopic diseases. We presented a pediatric case with a history of eczema, asthma, and recurrent atopic rhinitis, who first developed NS at age three, responding well to steroid therapy.

View Article and Find Full Text PDF

Generation of a virus-like particles based vaccine against IgE.

Allergy

August 2024

Department of Immunology, University Clinic for Rheumatology and Immunology, University of Bern, Bern, Switzerland.

Background: Anti-IgE immunotherapy with monoclonal antibodies represents a breakthrough in treatment of severe allergic diseases. However, drawbacks such as short half-life and high price are not negligible. Our objective is to develop an anti-IgE vaccine based on virus-like particles (VLPs) which can induce long-lasting neutralizing IgG anti-IgE antibodies reducing allergic responses without causing intrinsic mast cell activation due to IgE cross-linking.

View Article and Find Full Text PDF

Background: The value, if any, of anti-IgE approaches in the treatment of atopic dermatitis has not been fully clarified. Studies using the anti-IgE omalizumab have yielded conflicting results.

Objective: Antibodies with an IgE-suppressive capacity stronger than omalizumab might be more efficacious.

View Article and Find Full Text PDF

Background: The value of aeroallergen skin testing is not known in IgE deficient individuals (IgE<2.5 kU/L).

Objective: To investigate the utility of skin prick (SPT), intradermal skin testing (IDST) and measuring serum specific IgE (ssIgE) in IgE deficient patients presenting with environmental allergy-like symptoms.

View Article and Find Full Text PDF

The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence.

World Allergy Organ J

January 2021

Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria.

Since the discovery of IgE, almost all attention was given to conditions with elevated specific or total IgE levels such as atopy, type I hypersensitivity reactions, or parasitic infestations. Recent prospective and retrospective studies show that having very low IgE levels, such as those seen in IgE deficiency (IgE<2.5 kU/L), is not without clinical consequences.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!